A multicenter single‐arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2‐positive breast cancer
Shi, Qiyun, Qi, Xiaowei, Tang, Peng, Fan, Linjun, Chen, Li, Wang, Shushu, Liang, Yan, Hu, Ying, Wang, Minghao, Ren, Lin, Zhang, Guozhi, Tan, Xuanni, Yuan, Long, Du, Junze, Wu, Xiujuan, Wang, Mengyuan, Che, Hongying, Lv, Pengwei, Chen, Dejie, Hu, Jinhui, Li, Qiuyun, Zhang, Yanwu, Yang, Kunxian, Zhong, Yuan, Chen, Chuang, Zhou, Zemin, Qian, Liyuan, Zhang, Jingwei, Ma, Mingde, Sun, Yi, Zhang, Yi, Jiang, Jun
Published in MedComm (2020) (01.12.2023)
Published in MedComm (2020) (01.12.2023)
Get full text
Journal Article
Peripheral blood inflammatory indexes in breast cancer: A review
Xie, Jiaqiang, Guo, Zhenxi, Zhu, Yijing, Ma, Mingde, Jia, Guangwei
Published in Medicine (Baltimore) (01.12.2023)
Published in Medicine (Baltimore) (01.12.2023)
Get full text
Journal Article
JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis
Zuo, Yonggang, Ma, Mingde, Wen, Yuqing, Chang, Liang, Qu, Changping
Published in Clinical & translational oncology (01.07.2023)
Published in Clinical & translational oncology (01.07.2023)
Get full text
Journal Article
Core unit engineering of star-shaped acceptor polymers for all-polymer solar cells
Ma, Mingde, Ji, Qing, Yin, Luqi, Lin, Kai, Wen, Guanzhao, Xu, Yunxiang, Zhang, Nan, Dong, Geng, Yu, Liangmin, Zhang, Wei, Xu, Xiaofeng
Published in Solar energy (01.09.2020)
Published in Solar energy (01.09.2020)
Get full text
Journal Article
Abstract PO1-28-07: Neoadjuvant docetaxel plus cisplatin versus docetaxel plus doxorubicin and cyclophosphamide in early-stage triple-negative breast cancer (HNBC-001): results from a multicenter, randomized controlled, open-label phase II trial
Jiao, Dechuang, Qiao, Jianghua, Wang, Chengzheng, Li, Juntao, Sun, Xianfu, Lu, Zhenduo, Zhang, Chongjian, Li, Lianfang, Yan, Min, Feng, Yueqing, Zhou, Yong, Deng, Miao, Liu, Xinlan, Ma, Mingde, Jia, Haiquan, Xia, Qingxin, Chen, Xiuchun, Liu, Zhenzhen
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO1-27-05: De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab in HER2-positive early breast cancer (HELEN-006):a randomized,phase 3 trial
Liu, Zhenzhen, Chen, Xiuchun, Qiao, Jianghua, Dechuang, Jiao, Wang, Chengzheng, Sun, Xianfu, Lu, Zhenduo, Li, Lianfang, Zhang, Chongjian, Yan, Min, Wei, Ya, Bo, Chen, Feng, Yueqing, Deng, Miao, Ma, Mingde
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract OT2-22-01: Epirubicin, cyclophosphamide and pyrotinib followed by docetaxel, trastuzumab and pyrotinib as neoadjuvant therapy for stage II-III HER2-positive breast cancer: a single-arm, multicenter phase 2 trial
Shi, Qiyun, Qi, Xiaowei, Tang, Peng, Fan, Linjun, Chen, Li, Wang, Shushu, Zhang, Guozhi, Wang, Mengyuan, Che, Hongying, Lv, Pengwei, Chen, Dejie, Hu, Jinhui, Li, Qiuyun, Zhang, Yanwu, Yu, Qiao, Yang, Kunxian, Zhong, Yuan, Chen, Chuang, Zhou, Zemin, Qian, Liyuan, Zhang, Jingwei, Ma, Mingde, Sun, Yi, Liu, Jiangbo, Zhang, Yi, Jiang, Jun
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article